Skip to main content
OpenTrials

Clinical trial condition

Geographic Atrophy

Explore clinical trials studying Geographic Atrophy. Study availability and eligibility vary by location and protocol.

134 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Geographic Atrophy trial results

Completed

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

NCT07214740

Conditions
Eye Diseases, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, +3 more
Locations
  • California Retina Consultants Bakersfield, California, United States
  • California Retina Consultants Oxnard, California, United States
  • Austin Retina Associates Austin, Texas, United States
  • Retina Consultants of Texas Katy, Texas, United States
View Trial Details
Completed

Phase 2/3 Study of ALK-001 in Geographic Atrophy

NCT03845582

Conditions
AMD, Age Related Macular Degeneration, Atrophy, Geographic, +5 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Beverly Hills, California, United States
  • Alkeus Site Lakewood, Colorado, United States
  • Alkeus Site Clearwater, Florida, United States
View all 24 locations
View Trial Details
Completed

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

NCT04435366

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
  • Retina Consultants of Orange County Fullerton, California, United States
View all 205 locations
View Trial Details
Completed

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

NCT04679935

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Regensburg, Bavaria, Germany
  • Novartis Investigative Site Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Bonn, Germany
View all 19 locations
View Trial Details
Completed

A Study of NGM621 in Participants With Geographic Atrophy

NCT04465955

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 65 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

NCT04635800

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +12 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Honolulu, Hawaii, United States
  • Novartis Investigative Site Hagerstown, Maryland, United States
  • Novartis Investigative Site Austin, Texas, United States
View Trial Details
Completed

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

NCT04774926

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Acquaviva delle Fonti, BA, Italy
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Cagliari, CA, Italy
View all 20 locations
View Trial Details

Related conditions